Cemiplimab trials for Colorectal cancer

All Cemiplimab trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying Cemiplimab for Colorectal cancer

• A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
  NCT06412198 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
  NCT07058012 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
  NCT07281768 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
  NCT07433673 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
  NCT07147231 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations

Common questions

How many trials study Cemiplimab for Colorectal cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.